Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women

This study has been completed.
Information provided by:
Mayo Clinic Identifier:
First received: March 5, 2007
Last updated: January 14, 2010
Last verified: January 2010
To evaluate the effect of estrogen treatment on adipocytic and osteoblastic parameters by histomorphometrically measuring adipocyte volume (AV/TV) and adipocyte numbers in goldner's stained iliac crest bone biopsy specimens collected from subjects recruited in the study (IRB number 21B85). The adipocytic parameters will be then correlated with osteoblastic parameters obtained previously during the course of the initai study involving the effect of transdermal estrogen on bone turnover in postmenopausal osteoporotic women.

Condition Intervention
Drug: estrogen

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women

Resource links provided by NLM:

Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • efficacy of estraderm treatment on osteoporotic women

Estimated Enrollment: 60
Study Start Date: April 1985
Study Completion Date: April 1989
Primary Completion Date: April 1989 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   30 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Post-menopausal osteoporotic women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00443716

United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Principal Investigator: B. Lawrence Riggs, M.D. Mayo Clinic
  More Information Identifier: NCT00443716     History of Changes
Other Study ID Numbers: 05-004111
Study First Received: March 5, 2007
Last Updated: January 14, 2010

Additional relevant MeSH terms:
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs processed this record on May 24, 2017